Immediate Impact
102 standout
Citing Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
2021 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Works of G. D’Alessandro being referenced
Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy
2004
Myocardial Collagen Turnover in Hypertrophic Cardiomyopathy
2003
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| G. D’Alessandro | 238 | 43 | 27 | 49 | 9 | 285 | |
| Haresh Mehta | 188 | 42 | 115 | 110 | 7 | 292 | |
| Nicola Johnston | 122 | 32 | 72 | 44 | 15 | 211 | |
| Heesoo Yoo | 94 | 27 | 26 | 44 | 8 | 223 | |
| Omar Issa | 178 | 29 | 36 | 42 | 12 | 248 | |
| Frederique E.C.M. Peeters | 243 | 77 | 58 | 84 | 13 | 318 | |
| V. Pagliara | 177 | 54 | 53 | 15 | 8 | 287 | |
| Kenji Obata | 254 | 42 | 47 | 55 | 10 | 321 | |
| Elisa Bertacco | 183 | 95 | 53 | 23 | 12 | 325 | |
| Michael Deeb | 134 | 52 | 79 | 117 | 11 | 286 | |
| Gloria M. Gager | 147 | 30 | 62 | 19 | 14 | 249 |
All Works
Loading papers...